Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin plus statin versus statin alone in stable coronary artery disease
2005-003093-21Phase 2Completed
- Sponsor
- Medical Department I
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of niacin, atorvastatin, fluvastatin, pravastatin and simvastatin in coronary arteriosclerosis (2 arms), sponsored by Medical Department I. Primary endpoint: Endothelial progenitor cells and inflammatory biomarkers at 12 weeks. Started Jun 2006; status: completed.
02
Drugs
niacinatorvastatinfluvastatinpravastatinsimvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2005-003093-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003093-21.